RT @ElixirSymbol: As published in Journal of Inflammation, researchers found that VCE-004.8 (cannabidiol quinone derivative) may prove to b…
RT @ElixirSymbol: As published in Journal of Inflammation, researchers found that VCE-004.8 (cannabidiol quinone derivative) may prove to b…
As published in Journal of Inflammation, researchers found that VCE-004.8 (cannabidiol quinone derivative) may prove to be an effective treatment for multiple sclerosis by mediating neuroinflammation. #Cannabis #Mmemberville https://t.co/XJEv2YD5Kc
Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy https://t.co/ZIJctfcklA #MultipleSclerosis
RT @SEICannabinoide: Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.…
RT @SEICannabinoide: Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.…
RT @SEICannabinoide: Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.…
RT @ChimeraGenetics: VivaCell! https://t.co/4hY1Q3FyGj
VivaCell! https://t.co/4hY1Q3FyGj
RT @SEICannabinoide: Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.…
2018 is being a very productive year! Thesis last paper published!! https://t.co/tPC5hruEdn
RT @SEICannabinoide: Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.…
Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy. https://t.co/itkqeDLWSD